Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Rebus Biosystems logo — Spatial omics without compromise

Rebus Biosystems

Spatial omics without compromise

Founded 2006 United States Santa Clara, United States 12 employees Venture round Total: $37.76M Biotechnology

General Information

Company Name Rebus Biosystems
Founded Year 2006
Location United States Santa Clara, United States
Employees 12
Industries Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Rebus Biosystems. To contact Rebus Biosystems, visit rebusbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Rebus Biosystems compare?

A PDF of Rebus Biosystems and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Rebus Biosystems soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Rebus Biosystems

Rebus Biosystems is a biotechnology company founded in 2006 and headquartered in the United States. The company's slogan "Spatial omics without compromise" reflects its vision to provide subcellular resolution of biological molecules directly in and across large tissue sections. Rebus Biosystems offers customizable assays, enabling researchers to focus on the targets most relevant to their work. In early 2021, the company plans to introduce a fully automated, integrated instrument for laboratories. Notably, access is currently available through the Spatial Omics as a Service program. Rebus Biosystems recently secured a significant $17.76M Venture Round investment, signifying investor confidence in the company's innovative approach. With this investment, the company is poised to further develop its technology and expand its reach in the biotechnology industry. The venture's success is anticipated to drive impactful advancements in spatial omics research.

Business keywords: Spatial omics, Subcellular resolution, Biological molecules, Tissue sections, Customizable assays, Integrated instrument, Automated, Research, Scientific instrumentation, Research tools, Spatial Omics as a Service, Biomedical technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $17.76M -
03 Nov 2022
Series B $20.00M 7
Illumina Ventures NCore Ventures Lifecore Partners Inc.
Illumina Ventures, NCore Ventures +5
19 Nov 2020

Rebus Biosystems Alternatives & Competitors

View All Alternatives
Rebus Biosystems vs
Vizgen
Vizgen United States

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial...

Series E
153 employees
Biotechnology, Health Care
Rebus Biosystems vs
BellBrook Labs
BellBrook Labs United States

BellBrook Labs is dedicated to accelerating drug discovery and biological research.

Seed
19 employees
Biotechnology, Health Care
Rebus Biosystems vs
NanoString Technologies, Inc.
NanoString Technologies, Inc. United States

Mapping the universe of biology 🧬

IPO
225 employees
Biotechnology, Health Care
View all alternatives

FAQ About Rebus Biosystems

Spatial omics without compromise
Rebus Biosystems was founded in 2006.
Rebus Biosystems is headquartered in Santa Clara, United States.
Rebus Biosystems operates in Biotechnology. Its work centres on Spatial omics, Subcellular resolution, Biological molecules and Tissue sections.
Rebus Biosystems has approximately 12 employees.
Rebus Biosystems has completed 2 funding rounds, raising a total of $37.76M. The latest funding stage is Venture round.
Top alternatives and competitors to Rebus Biosystems include Vizgen, BellBrook Labs, NanoString Technologies, Inc., ONI, CARTANA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rebus Biosystems and Vizgen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rebus Biosystems, https://bouncewatch.com/company/rebus-biosystems, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes